Monoclonal antibodies in oncology.
Open Access
- 1 April 1982
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 35 (4) , 369-375
- https://doi.org/10.1136/jcp.35.4.369
Abstract
Molecular biology has made tremendous strides over the last five years. The new biology allows us to prepare monoclonal antibodies to defined antigens; to detect, isolate and clone specific genes; and to insert these genes into defined sites in different cells giving new functions to old organisms. These revolutionary developments have been followed closely by researchers, businessmen, politicians and philosophers, as well as by those involved in the clinical care of patients. Although our understanding of human molecular biology is increasing rapidly, it is the development of monoclonal antibodies that has the most immediate application in the clinic. There have been several reports of their use in the diagnosis, localisation and treatment of human malignant disease. This review describes developments that are likely to have direct relevance to patient care in the near future.Keywords
This publication has 24 references indexed in Scilit:
- Immuno-histological diagnosis of lymphoproliferative diseases by selected combinations of antisera and monoclonal antibodiesBritish Journal of Cancer, 1980
- LOCALIZATION OF I-131-LABELED TUMOR-SPECIFIC MONOCLONAL-ANTIBODY IN THE TUMOR-BEARING BALB-C MOUSE1980
- Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines.Proceedings of the National Academy of Sciences, 1980
- Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.BMJ, 1979
- Partial purification of tumour-specific transplantation antigens from methylcholanthrene-induced murine sarcomas by immobilized lectinsBritish Journal of Cancer, 1979
- Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.Proceedings of the National Academy of Sciences, 1979
- Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.The Journal of Experimental Medicine, 1976
- Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusionEuropean Journal of Immunology, 1976
- LYMPHOCYTE CYTOTOXICITY IN BLADDER CANCER NO REQUIREMENT FOR THYMUS-DERIVED EFFECTOR CELLS ?The Lancet, 1973
- Host Resistance and Survival in Carcinoma of Breast: A Study of 104 Cases of Medullary Carcinoma in a Series of 1,411 Cases of Breast Cancer Followed for 20 yearsBMJ, 1970